MyFinsight
Home
Blog
About
Blend Labs, Inc. (BLND)
Blend Labs, Inc. (BLND)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
$7,102K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Stock-based compensation
Trade and other receivables
Depreciation and amortization
Others
Negative Cash Flow Breakdown
Share repurchases
Deferred revenue
Net loss from continuing operati...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss from continuing operations
-1,812
-5,465
-3,281
12,410
Stock-based compensation
6,978
6,780
7,579
7,766
Depreciation and amortization
1,514
1,337
1,200
1,041
Amortization of deferred contract costs
317
475
451
429
Amortization of debt discount and issuance costs
-
-
0
0
Amortization of operating lease right-of-use assets
87
123
181
151
Accelerated amortization of right-of-use asset in connection with lease abandonment
-
-
0
0
Gain on conversion of note receivable to investment in equity securities
-
-
-825
-
Gain on investment in equity securities
-
-
0
16,580
Loss on extinguishment of debt
-
-
0
0
Gain on sale of insurance business
-
-
0
0
Equity in losses of equity method investees, net of tax
-338
-381
-
-
Other
-210
-412
-43
39
Trade and other receivables
-3,398
9,061
-3,415
-2,709
Prepaid expenses and other assets, current and non-current
765
-1,144
721
3,447
Deferred contract costs, non-current
-169
-43
289
-263
Accounts payable
159
-1,599
1,054
-429
Deferred revenue
-2,539
14,637
-5,940
-7,421
Accrued compensation
-444
-543
-159
1,650
Operating lease liabilities
-86
-120
-136
-712
Other liabilities, current and non-current
214
-82
-234
-524
Net cash provided by operating activities - continuing operations
7,738
8,462
2,338
-2,733
Net cash used in operating activities - discontinued operations
189
-1,110
-1,358
-757
Net cash provided by operating activities
7,927
7,352
980
-3,490
Purchases of marketable securities
0
4,966
4,995
6,741
Sale of available-for-sale securities
0
0
0
19,968
Maturities of marketable securities
0
8,000
2,500
16,500
Additions to property, equipment and internal-use software development costs
825
1,117
1,001
2,272
Investment in note receivable
-
-
0
-
Other
-
-
0
0
Proceeds from sale of insurance business
-
-
0
0
Cash received in connection with conversion of note receivable to investment in equity securities
-
-
2,255
-
Investment in non-marketable equity securities
0
-
0
0
Net cash provided by (used in) investing activities - continuing operations
-825
1,917
-1,241
27,455
Net cash provided by (used in) investing activities - discontinued operations
140
970
-13
-62
Net cash provided by (used in) investing activities
-685
2,887
-1,254
27,393
Proceeds from exercises of stock options, including early exercises, net of repurchases
0
96
147
712
Taxes paid related to net share settlement of equity awards
937
1,127
1,981
1,886
Share repurchases
20,405
16,836
15,727
5,025
Repayment of long-term debt
-
-
0
0
Net proceeds from the issuance of the series a redeemable convertible preferred stock and the haveli warrant
-
-
0
0
Payment for issuance costs related to the series a redeemable convertible preferred stock and the haveli warrant
-
-
0
0
Net cash used in financing activities
-21,342
-17,867
-17,561
-6,199
Effect of exchange rates on cash, cash equivalents, and restricted cash
-19
-5
0
0
Net decrease in cash, cash equivalents, and restricted cash
-14,119
-7,633
-17,835
17,704
Cash, cash equivalents, and restricted cash at beginning of period
39,365
46,998
64,833
49,537
Cash, cash equivalents, and restricted cash at end of period
25,246
39,365
46,998
64,833
Less cash, cash equivalents and restricted cash included in current assets held for sale from discontinued operations
0
0
3,420
-
Cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale from discontinued operations
25,246
-
-
-
Cash and cash equivalents
23,311
-
-
-
Restricted cash
1,935
-
-
-
Total cash, cash equivalents, and restricted cash
25,246
39,365
43,578
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Stock-based compensation
$6,978K
(-48.73%↓ Y/Y)
Trade and other
receivables
-$3,398K
(-1033.52%↓ Y/Y)
Depreciation and
amortization
$1,514K
(44.60%↑ Y/Y)
Equity in losses of
equity method...
-$338K
Amortization of deferred
contract costs
$317K
(-57.51%↓ Y/Y)
Other liabilities,
current and non-current
$214K
(-90.32%↓ Y/Y)
Other
-$210K
(-166.46%↓ Y/Y)
Deferred contract costs,
non-current
-$169K
(-131.83%↓ Y/Y)
Accounts payable
$159K
(137.95%↑ Y/Y)
Amortization of operating
lease right-of-use...
$87K
(-56.28%↓ Y/Y)
Net cash provided by
operating activities -...
$7,738K
(-47.69%↓ Y/Y)
Net cash used in
operating activities -...
$189K
(124.51%↑ Y/Y)
Canceled cashflow
$5,646K
Net cash provided by
operating activities
$7,927K
(-43.47%↓ Y/Y)
Deferred revenue
-$2,539K
(-119.94%↓ Y/Y)
Net loss from
continuing operations
-$1,812K
(82.33%↑ Y/Y)
Prepaid expenses and
other assets, current...
$765K
(-39.38%↓ Y/Y)
Accrued compensation
-$444K
(35.09%↑ Y/Y)
Operating lease
liabilities
-$86K
(95.52%↑ Y/Y)
Net decrease in
cash, cash...
-$14,119K
(-486.34%↓ Y/Y)
Canceled cashflow
$7,927K
Net cash provided by
(used in) investing...
$140K
(216.67%↑ Y/Y)
Net cash used in
financing activities
-$21,342K
(-141.78%↓ Y/Y)
Net cash provided by
(used in) investing...
-$685K
(90.99%↑ Y/Y)
Effect of exchange
rates on cash, cash...
-$19K
Canceled cashflow
$140K
Share repurchases
$20,405K
(395.51%↑ Y/Y)
Taxes paid related to
net share...
$937K
(-82.97%↓ Y/Y)
Net cash provided by
(used in) investing...
-$825K
(88.98%↑ Y/Y)
Additions to property,
equipment and...
$825K
(-90.08%↓ Y/Y)
Buy us a coffee